Key result
Bayés' Syndrome links interatrial conduction defects to AF and increased cardioembolic risk.
Why the study?
Prediction and early detection of atrial fibrillation remain a permanent challenge, requiring timely identification of increased AF risk for prevention of cardioembolic events.
Answers are grounded in this paper and cite their sources.
Bayés' Syndrome denotes the association between interatrial conduction defect and supraventricular arrhythmias (mainly atrial fibrillation), which predisposes patients to cardioembolic events.
Prediction and early detection of atrial fibrillation (AF) remain a permanent challenge in everyday practice. Timely identification of an increased risk for AF episodes (which are frequently asymptomatic) is essential in the primary and secondary prevention of cardioembolic events. One of the noninvasive modalities of AF prediction is represented by the electrocardiographic P-wave analysis. This includes the study and diagnosis of interatrial conduction block (Bachmann's bundle block). Bayés' Syndrome (named after its first descriptor) denotes the association between interatrial conduction defect and supraventricular arrhythmias (mainly AF) predisposing to cardioembolic events. Our short review presents an update of the most important data concerning this syndrome: brief history, main ECG features, pathophysiological background and clinical implications.
No takes yet. Share an insight, caveat, or question.
Murariu et al. (2020) conducted a review in Bayés' Syndrome / Atrial Fibrillation. Bayés' Syndrome was evaluated. Bayés' Syndrome denotes the association between interatrial conduction defect and supraventricular arrhythmias, mainly atrial fibrillation, which predisposes patients to cardioembolic events.
Synapse has enriched 10 related papers. Consider them for comparative context: